Farmacología y Toxicología
Departamento
University of Bologna
Bolonia, ItaliaPublicaciones en colaboración con investigadores/as de University of Bologna (11)
2023
-
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022
European Heart Journal - Cardiovascular Pharmacotherapy, Vol. 9, Núm. 4, pp. 353-370
2022
-
Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 4, pp. 406-419
2021
-
Outcomes from elective colorectal cancer surgery during the SARS-CoV-2 pandemic
Colorectal Disease, Vol. 23, Núm. 3, pp. 732-749
-
Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: A review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
European Heart Journal - Cardiovascular Pharmacotherapy, Vol. 7, Núm. 6, pp. 557-567
2020
-
Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: Systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases
European Heart Journal - Cardiovascular Pharmacotherapy, Vol. 6, Núm. 2, pp. 86-93
2019
-
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: A current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke
European Heart Journal - Cardiovascular Pharmacotherapy, Vol. 5, Núm. 3, pp. 171-180
-
Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): A multicentre, prospective observational study
The Lancet Respiratory Medicine, Vol. 7, Núm. 2, pp. 129-140
-
Quinoxalinetacrine QT78, a cholinesterase inhibitor as a potential ligand for Alzheimer’s disease therapy
Molecules, Vol. 24, Núm. 8
2017
-
5-Methyl-: N -(8-(5,6,7,8-tetrahydroacridin-9-ylamino)octyl)-5 H -indolo[2,3- b] quinolin-11-amine: A highly potent human cholinesterase inhibitor
MedChemComm, Vol. 8, Núm. 6, pp. 1307-1317
2015
-
Novel tacrine-grafted ugi adducts as multipotent anti-alzheimer drugs: A synthetic renewal in tacrine-ferulic acid hybrids
ChemMedChem, Vol. 10, Núm. 3, pp. 523-539
2012
-
Mortality after surgery in Europe: A 7 day cohort study
The Lancet, Vol. 380, Núm. 9847, pp. 1059-1065